Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2010

01-06-2010 | Original Article

Overexpression of Protein Phosphatase Non-receptor Type 11 (PTPN11) in Gastric Carcinomas

Authors: Jin Soo Kim, Ok Ran Shin, Hyung Keun Kim, Young Seok Cho, Chang Hyeok An, Keun Woo Lim, Sung Soo Kim

Published in: Digestive Diseases and Sciences | Issue 6/2010

Login to get access

Abstract

Background

Tyrosine phosphorylation and dephosphorylation by protein tyrosine kinases and phosphatases (PTPs), respectively, play crucial roles in cellular signal transduction. Protein phosphatase non-receptor type 11 (PTPN11) is a positive signaling PTP that activates RAS and ERK signaling. Also, the PTPN11 binds with CagA of Helicobacter pylori in gastric epithelial cells.

Aim

The aim of this study was to explore whether alteration of PTPN11 protein expression is a feature of gastric cancer cells.

Methods

We analyzed PTPN11 expression in 92 gastric cancer tissues by immunohistochemistry using a tissue microarray method.

Results

The gastric cancers expressed PTPN11 in 78 (87%) specimens, while the epithelial cells in normal gastric mucosa did not display any PTPN11 immunoreactivity. The PTPN11 expression in the cancers was associated with the tubular morphology (versus signet ring cell type), the Lauren’s intestinal type (versus diffuse type), and the advanced gastric cancer type (versus early gastric cancer type).

Conclusion

Our data indicate that gastric cancers display a higher expression of PTPN11 protein than the normal cells, suggesting that neo-expression of this positive signaling protein in the cells might play a role in the cancer development. Also, the higher expression of PTPN11 in tubular and intestinal types, where Helicobacter pylori has a definite role in the development of the cancers, suggest a possibility that PTPN11 might play a role in regulation in Helicobacter pylori pathogenesis the gastric cancers.
Literature
1.
go back to reference Ostman A, Böhmer FD. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol. 2001;11:258–266.CrossRefPubMed Ostman A, Böhmer FD. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol. 2001;11:258–266.CrossRefPubMed
2.
go back to reference Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997;9:193–204.CrossRefPubMed Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997;9:193–204.CrossRefPubMed
3.
go back to reference Li L, Dixon JE. Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin Immunol. 2000;12:75–84.CrossRefPubMed Li L, Dixon JE. Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin Immunol. 2000;12:75–84.CrossRefPubMed
4.
5.
go back to reference Neel BG, Gu H, Pao L. The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003;28:284–293.CrossRefPubMed Neel BG, Gu H, Pao L. The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003;28:284–293.CrossRefPubMed
7.
go back to reference Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Comprehensive review of Noonan syndrome and its affiliated disorders, including discussion of mutational spectrum, phenotypic features and pathogenic mechanisms. Annu Rev Genomics Hum Genet. 2005;6:45–68.CrossRefPubMed Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Comprehensive review of Noonan syndrome and its affiliated disorders, including discussion of mutational spectrum, phenotypic features and pathogenic mechanisms. Annu Rev Genomics Hum Genet. 2005;6:45–68.CrossRefPubMed
8.
go back to reference Tartaglia M, Niemeyer CM, Fragale A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003;34:148–150.CrossRefPubMed Tartaglia M, Niemeyer CM, Fragale A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003;34:148–150.CrossRefPubMed
9.
go back to reference Bentires-Alj M, Paez JG, David FS, et al. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 2004;64:8816–8820.CrossRefPubMed Bentires-Alj M, Paez JG, David FS, et al. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 2004;64:8816–8820.CrossRefPubMed
10.
go back to reference Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295:683–686.CrossRefPubMed Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295:683–686.CrossRefPubMed
11.
go back to reference Yamazaki S, Yamakawa A, Ito Y, et al. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis. 2003;187:334–337.CrossRefPubMed Yamazaki S, Yamakawa A, Ito Y, et al. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis. 2003;187:334–337.CrossRefPubMed
12.
go back to reference Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004;4:688–694.CrossRefPubMed Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004;4:688–694.CrossRefPubMed
13.
go back to reference Lee SH, Shin MS, Park WS, et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene. 1999;18:3754–3760.CrossRefPubMed Lee SH, Shin MS, Park WS, et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene. 1999;18:3754–3760.CrossRefPubMed
14.
go back to reference Zhou X, Coad J, Ducatman B, Agazie YM. SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis. Histopathology. 2008;53:389–402.CrossRefPubMed Zhou X, Coad J, Ducatman B, Agazie YM. SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis. Histopathology. 2008;53:389–402.CrossRefPubMed
15.
go back to reference Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119:265–272.CrossRefPubMed Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119:265–272.CrossRefPubMed
16.
go back to reference Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed
17.
go back to reference Martín-de-Argila C, Boixeda D, Redondo C, et al. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. Scand J Gastroenterol. 1997;32:303–307.CrossRefPubMed Martín-de-Argila C, Boixeda D, Redondo C, et al. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. Scand J Gastroenterol. 1997;32:303–307.CrossRefPubMed
18.
go back to reference Trajkov D, Stardelova K, Dimitrova M, Mishevski J, Serafimoski V. Helicobacter pylori and gastric carcinoma. Prilozi. 2007;28:39–46.PubMed Trajkov D, Stardelova K, Dimitrova M, Mishevski J, Serafimoski V. Helicobacter pylori and gastric carcinoma. Prilozi. 2007;28:39–46.PubMed
19.
go back to reference Hatakeyama M. Helicobacter pylori CagA–a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer. 2006;119:1217–1223.CrossRefPubMed Hatakeyama M. Helicobacter pylori CagA–a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer. 2006;119:1217–1223.CrossRefPubMed
Metadata
Title
Overexpression of Protein Phosphatase Non-receptor Type 11 (PTPN11) in Gastric Carcinomas
Authors
Jin Soo Kim
Ok Ran Shin
Hyung Keun Kim
Young Seok Cho
Chang Hyeok An
Keun Woo Lim
Sung Soo Kim
Publication date
01-06-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0924-z

Other articles of this Issue 6/2010

Digestive Diseases and Sciences 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine